Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Press releases

November 26, 2015

Immunovia approved for trading on Nasdaq First North as of December 1st, 2015

Read press release
October 5, 2015

Immunovia, OHSU collaborating on early detection test for pancreatic cancer

Read press release
1 25 26 27